Literature DB >> 26946932

NOD2 gene variant is a risk factor for postoperative complications in patients with Crohn's disease: A genetic association study.

Adeline Germain1, Rosa-Maria Guéant2, Mathias Chamaillard3, Patrick B Allen4, Laurent Bresler5, Jean-Louis Guéant2, Laurent Peyrin-Biroulet6.   

Abstract

BACKGROUND: Postoperative complications are relatively frequent in Crohn's disease (CD) and several risk factors have been identified. The influence of genetic factors, however is unknown.
METHODS: CD patients who underwent CD-related bowel resection were identified from the "Nancy IBD cohort." Postoperative complications were defined as intraabdominal infectious complications and non-intraabdominal infectious complications occurring within 90 days after operation. The influence of 203 single nucleotide polymorphisms on postoperative complication rates was analyzed.
RESULTS: Of the 137 patients who had undergone a CD-related bowel resection in our cohort, postoperative complications occurred in 34 cases (24.8%). Postoperative intraabdominal infections occurred in 18 cases (13.1%): 12 had anastomotic leakage and 6 had intraabdominal abscesses. In multivariate analysis, current smoker status (odds ratio [OR], 2.71; 95% CI, 1.18-6.21; P = .02) and homozygosity for the risk allele (T) Nucleotide-binding Oligomerization Domain-containing protein 2 (rs5743289; NOD2; OR, 2.07 [95% CI 1.15-3.72]; P = .01) were independent risk factors of postoperative intraabdominal infectious complications. Current smoker status NOD2 homozygosity for the risk allele (T) were not associated with non-intraabdominal infectious complications.
CONCLUSION: Current smoker status was associated with increased risk of postoperative intraabdominal infectious complications. A novel association between the NOD2 allele and an increased risk of postoperative intraabdominal infectious complications was observed in this study.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26946932     DOI: 10.1016/j.surg.2016.01.013

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

Review 1.  Pharmacogenetic biomarkers of response in Crohn's disease.

Authors:  T M Linares-Pineda; M Cañadas-Garre; A Sánchez-Pozo; M Á Calleja-Hernández
Journal:  Pharmacogenomics J       Date:  2017-06-20       Impact factor: 3.550

2.  Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.

Authors:  Shivi Siva; David T Rubin; George Gulotta; Kristin Wroblewski; Joel Pekow
Journal:  Inflamm Bowel Dis       Date:  2017-01       Impact factor: 5.325

3.  Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.

Authors:  Ellen Li; Yuanhao Zhang; Xinyu Tian; Xuefeng Wang; Grace Gathungu; Ashley Wolber; Shehzad S Shiekh; R Balfour Sartor; Nicholas O Davidson; Matthew A Ciorba; Wei Zhu; Leah M Nelson; Charles E Robertson; Daniel N Frank
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

4.  Single Nucleotide Polymorphisms and Post-operative Complications Following Major Gastrointestinal Surgery: a Systematic Review and Meta-analysis.

Authors:  Joseph Beecham; Andrew Hart; Leo Alexandre; James Hernon; Bhaskar Kumar; Stephen Lam
Journal:  J Gastrointest Surg       Date:  2019-07-03       Impact factor: 3.452

5.  Effect of Huangqin decoction on regulating intestinal flora in colitis mice characterized as inhibition of the NOD2-dependent pathway.

Authors:  Shaowei Huang; Jinrong He; Yanping Chen; Xiaojing Wang; Yanyang Li; Yulin Su; Ruyan Wen; Xiuling Li; Guanghua Yang; Shuang Luo; Lian Zhou; Xia Luo
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

6.  It is not NOD2 - genetic and clinical risk factors for postoperative complications following ileocolic resection in Crohn's disease.

Authors:  Josefine Schardey; Sophie Zehl; Alina S Kappenberger; Petra Zimmermann; Florian Beigel; Tobias S Schiergens; Michael S Kasparek; Florian Kühn; Jens Werner; Ulrich Wirth
Journal:  Int J Colorectal Dis       Date:  2022-08-01       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.